02380 408 600 Contact us
Menu
×

Publications

  • Publication Subject

  • Filter by Author

Did knowledge, opinions, background, and health authority advice influence early prescribing of the novel Alzheimer’s disease drug donepezil in general practice? – National postal survey

  • Author

    R M Martin E Rink D G Wilkinson R D Mann

    Richard Martin, Elizabeth Rink, David Wilkinson, Ronald Mann

  • Cite

    Pharmacoepidemiol Drug Saf. 1999 Oct;8(6):413-22

View Publication

Stevens-Johnson syndrome and antiepileptics

  • Author

    N Dunn L Wilton S Shakir

    Nick Dunn, Lynda Wilton, Saad Shakir

  • Cite

    Lancet. 1999 Sep 18;354(9183):1033-4

View Publication

Losartan: A study of pharmacovigilance data on 14,522 patients

  • Author

    R Mann F Mackay G Pearce S Freemantle L Wilton

    Ronald Mann, Fiona Mackay, Gillian Pearce, Shayne Freemantle, Lynda Wilton

  • Cite

    J Hum Hypertens. 1999 Aug;13(8):551-7

View Publication

Cohort study on calcium channel blockers, other cardiovascular agents, and the prevalence of depression

  • Author

    N R Dunn S N Freemantle R D Mann

    Nick Dunn, Shayne Freemantle, Ronald Mann

  • Cite

    Br J Clin Pharmacol. 1999 Aug;48(2):230-3

View Publication

Case and control recruitment, and validation of cases for the MICA case-control study in England, Scotland and Wales

  • Author

    N R Dunn A Arscott M Thorogood S Thomas H Davison J Richardson

    Nick Dunn, Ann Arscott, Margaret Thorogood, Simon Thomas, H Davison, J Richardson

  • Cite

    Pharmacoepidemiol Drug Saf. 1999 Jul;8(4):285-90

View Publication

The issue of data privacy and confidentiality in Europe – 1998

  • Author

    R D Mann A Bertelsmann

    Ronald Mann, Annekarin Bertelsmann

  • Cite

    Pharmacoepidemiol Drug Saf. 1999 Jul;8(4):261-4

View Publication

Correction: Oral contraceptives and myocardial infarction: Results of the MICA case-control study (British Medical Journal (1999) 12 June (1579-1584))

  • Author

    N Dunn M Thorogood B Faragher L de Caestecker T M MacDonald C McCollum S Thomas R Mann

    Nick Dunn, Margaret Thorogood, Brian Faragher, Linda de Caestecker, Thomas MacDonald, Charles McCollum, Simon Thomas, Ronald Mann

  • Cite

    BMJ. 1999 Jun 12;318(7198):1579-83

View Publication

Prevalence of Churg-Strauss syndrome, vasculitis, eosinophilia and associated conditions: Retrospective analysis of 58 prescription-event monitoring cohort studies

  • Author

    R M Martin L V Wilton R D Mann

    Richard Martin, Lynda Wilton, Ronald Mann

  • Cite

    Pharmacoepidemiol Drug Saf. 1999 May;8(3):179-89

View Publication

Safety profile of nicorandil – Prescription-event monitoring (PEM) study

  • Author

    N Dunn S Freemantle G Pearce L V Wilton R D Mann

    Nick Dunn, Shayne Freemantle, Gillian Pearce, Lynda Wilton, Ronald Mann

  • Cite

    Pharmacoepidemiol Drug Saf. 1999 May;8(3):197-205

View Publication

Nicorandil and diabetes: A nested case-control study to examine a signal generated by prescription-event monitoring

  • Author

    N Dunn S Freemantle R Mann

    Nick Dunn, Shayne Freemantle, Ronald Mann

  • Cite

    Eur J Clin Pharmacol. 1999 Apr;55(2):159-62

View Publication

Interim report on the incidence of visual field defects in patients on long term vigabatrin therapy

  • Author

    L V Wilton M D Stephens R D Mann

    Lynda Wilton, Myles Stephens, Ronald Mann

  • Cite

    Pharmacoepidemiol Drug Saf. 1999 Apr;8 Suppl 1:S9-14

View Publication

The use of newly marketed drugs in children and adolescents prescribed in general practice

  • Author

    L V Wilton G Pearce R D Mann

    Lynda Wilton, Gillian Pearce, Ronald Mann

  • Cite

    Pharmacoepidemiol Drug Saf. 1999 Apr;8 Suppl 1:S37-45

View Publication

Design of a pilot prospective cohort study of adverse events monitored by hospital pharmacists

  • Author

  • Cite

    Int J Pharm Med. January 1999

View Publication

Cough and angiotensin II receptor antagonists: Cause or confounding?

  • Author

    F J Mackay G L Pearce R D Mann

    Fiona Mackay, Gillian Pearce, Ronald Mann

  • Cite

    Br J Clin Pharmacol. 1999 Jan;47(1):111-4

View Publication

Cardiac risks with beta agonists

  • Author

    B Lindmark

  • Cite

    Thorax. 1998 Dec;53(12):1094-5

View Publication

Age and sex distribution of suspected adverse drug reactions to newly marketed drugs in general practice in England: Analysis of 48 cohort studies

  • Author

    R M Martin P N Biswas S N Freemantle G L Pearce R D Mann

    Richard Martin, Pipasha Biswas, Shayne Freemantle, Gillian Pearce, Ronald Mann

  • Cite

    Br J Clin Pharmacol. 1998 Nov;46(5):505-11

View Publication

Post-marketing studies. The work of the drug safety research unit

  • Author

    F J Mackay

    Fiona Mackay

  • Cite

    Drug Saf. 1998 Nov;19(5):343-53

View Publication

Prescription-event: Monitoring-recent progress and future horizons

  • Author

    R D Mann

    Ronald Mann

  • Cite

    Br J Clin Pharmacol. 1998 Sep;46(3):195-201

View Publication

The outcomes of pregnancy in women exposed to newly marketed drugs in general practice in England

  • Author

    L V Wilton G L Pearce R M Martin F J Mackay R D Mann

    Lynda Wilton, Gillian Pearce, Richard Martin, Fiona Mackay, Ronald Mann

  • Cite

    Br J Obstet Gynaecol. 1998 Aug;105(8):882-9

View Publication

Is the incidence of upper respiratory tract infection independent of drug treatment in large cohort studies of longer term use drugs?

  • Author

    L V Wilton S N Freemantle R Martin R D Mann

    Lynda Wilton, Shayne Freemantle, Richard Martin, Ronald Mann

  • Cite

    Pharmacoepidemiol Drug Saf. 1998 Aug;7 Suppl 1:S4-10

View Publication

Trends in prescribing H2-receptor antagonists and proton pump inhibitors in primary care

  • Author

    R M Martin A G Lim S M Kerry S R Hilton

    Richard Martin, Aik Guan Lim, , Sean Hilton

  • Cite

    Aliment Pharmacol Ther. 1998 Aug;12(8):797-805

View Publication

Unlicensed and off label drug use for paediatric patients. General practitioners prescribe SSRIs to children off label

  • Author

    R M Martin L V Wilton R D Mann P Steventon S R Hilton

    Richard Martin, Lynda Wilton, Ronald Mann, Paul Steventon, Sean Hilton

  • Cite

    BMJ. 1998 Jul 18;317(7152):204

View Publication

Underreporting of suspected adverse drug reactions to newly marketed (‘black triangle’) drugs in general practice: Observational study

  • Author

    R M Martin K V Kapoor L V Wilton R D Mann

    Richard Martin, Karan Kapoor, Lynda Wilton, Ronald Mann

  • Cite

    BMJ. 1998 Jul 11;317(7151):119-20

View Publication

Nefazodone in community use: The results of prescription-event monitoring

  • Author

    F J Mackay G L Pearce S N Freemantle R D Mann

    Fiona Mackay, Gillian Pearce, Shayne Freemantle, Ronald Mann

  • Cite

    Pharmacoepidemiol Drug Saf. 1999 Jul;8(4):267-73

View Publication

Prescription-event and other forms of epidemiological monitoring of side-effects in the UK

  • Author

    N Dunn R D Mann

    Nick Dunn, Ronald Mann

  • Cite

    Clin Exp Allergy. 1999 Jul;29 Suppl 3:217-39

View Publication